Are you really performing a correct Ligand-Protein interaction? Keep attention, you may perform wrong in majority of times................... USE BIOLOGICAL SENSES for DOCKING studies

Post has attachment

Foot prints towards personalised medicine for cancer:
2016: Prioritization of anticancer drugs against a cancer using genomic features of cancer cells: A step towards personalized medicine. PMCID: PMC4814902.
2016: A Landscape of Pharmacogenomic Interactions in Cancer. PMID: 27397505 PMCID: PMC4967469.
2015: Towards personalized medicine: chemosensitivity assays of patient lung cancer cell spheroids in a perfused microfluidic platform. PMID: 26088102.
2012: Personalized medicine: patient-predictive panel power. PMID: 22516256.
2012: Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape? PMID: 22838953.
2011: Matching cancer genomes to established cell lines for personalized oncology. PMID: 21121052 PMCID: PMC3477496

Post has attachment
Your designed molecule may be more valuable than your expectation, unravel it fast.

Trace activity of your compound with CBBE (

Queries are welcome by email.

Post has attachment
Queries are welcome for identification of possible activity of any small molecule against known target/s. ....
You may preferably contact through Email: with details of small molecule to be tested.

Post has attachment

Post has attachment
A look, How close Computational modeling works in Reality...
Wait while more posts are being loaded